Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients

NCT03949374 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Hypercholesterolemia
Dyslipidemias

Interventions

DRUG: CRESTOR, reference formulation of rosuvastatin
DRUG: ROVASRO, generic formulation of rosuvastatin

Sponsor

Yonsei University